Cleary Gottlieb Guides GSK's $2B Buy Of Liver-Disease Drug
Pharmaceutical giant GSK PLC said Wednesday that it plans to buy a drug for treating liver disease for up to $2 billion from Boston Pharmaceuticals in the U.S. to boost its hepatology...To view the full article, register now.
Already a subscriber? Click here to view full article